Hims Hers Health Inc (HIMS)
$30.02 -$0.31 (-1.03%) 4:38 PM 12/13/24
NYSE | $USD | Household & Personal ProductsStock Data
-
Market Cap
$7.48B -
Day's Range
$28.40 - $30.60 -
Volume
16,505,010 -
52 Week Low / High
$8.09 - $35.02 -
PE Ratio
77.80x -
PEG Ratio
- -
Dividend Frequency
-
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
- 3
- Strong Buy
- 2
- Buy
- 7
- Hold
- 1
- Sell
- 0
- Strong Sell
- $12.30
- Target Price
Company News
-
Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024
Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....
-
Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024
Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....
-
Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024
Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....
-
Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024
Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....
-
Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024
Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....
-
Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024
On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...
-
Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024
Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....
-
Top US Growth Companies With High Insider Ownership In October 2024 — Oct 21st, 2024
As of October 2024, U.S. stock markets have been experiencing their longest winning streak of the year, with major indices like the S&P 500 and Dow Jones Industrial Average reaching record highs. In this favorable market environment, growth companies with high insider ownership can be part...
-
Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024
Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....
-
Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024
On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...
-
Top US Growth Companies With High Insider Ownership In October 2024 — Oct 21st, 2024
As of October 2024, U.S. stock markets have been experiencing their longest winning streak of the year, with major indices like the S&P 500 and Dow Jones Industrial Average reaching record highs. In this favorable market environment, growth companies with high insider ownership can be part...
-
Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024
Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....
-
Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024
Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....
-
Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024
Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....
-
Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024
Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....
-
Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024
On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...
-
Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024
On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...
-
Top US Growth Companies With High Insider Ownership In October 2024 — Oct 21st, 2024
As of October 2024, U.S. stock markets have been experiencing their longest winning streak of the year, with major indices like the S&P 500 and Dow Jones Industrial Average reaching record highs. In this favorable market environment, growth companies with high insider ownership can be part...
-
Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024
Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....
-
Top US Growth Companies With High Insider Ownership In October 2024 — Oct 21st, 2024
As of October 2024, U.S. stock markets have been experiencing their longest winning streak of the year, with major indices like the S&P 500 and Dow Jones Industrial Average reaching record highs. In this favorable market environment, growth companies with high insider ownership can be part...
-
Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers — Oct 21st, 2024
Bringing expertise on women’s health at every age, Shepherd joins Hims & Hers to help more women access personalized care. (Photo: Business Wire) Bringing expertise on women’s health at every age, Shepherd joins Hims & Hers to help more women access personalized care SAN FRANCISCO, O...
-
Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024
Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....
-
Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024
On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...
-
Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024
On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...
-
Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024
Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....
-
Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024
Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....
-
Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024
On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...
-
Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024
Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....
-
Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024
On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...
-
Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024
Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....
-
Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024
Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....
-
Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024
Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....
-
Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024
On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...
-
Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024
Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....
-
Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024
On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...
-
Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024
Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....
-
Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers — Oct 21st, 2024
Bringing expertise on women’s health at every age, Shepherd joins Hims & Hers to help more women access personalized care. (Photo: Business Wire) Bringing expertise on women’s health at every age, Shepherd joins Hims & Hers to help more women access personalized care SAN FRANCISCO, O...
-
Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024
Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....
-
Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024
Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....
-
Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024
Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....
-
Top US Growth Companies With High Insider Ownership In October 2024 — Oct 21st, 2024
As of October 2024, U.S. stock markets have been experiencing their longest winning streak of the year, with major indices like the S&P 500 and Dow Jones Industrial Average reaching record highs. In this favorable market environment, growth companies with high insider ownership can be part...
-
Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers — Oct 21st, 2024
Bringing expertise on women’s health at every age, Shepherd joins Hims & Hers to help more women access personalized care. (Photo: Business Wire) Bringing expertise on women’s health at every age, Shepherd joins Hims & Hers to help more women access personalized care SAN FRANCISCO, O...
-
Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024
On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...
-
Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024
On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...
-
Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024
Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....
-
Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024
On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...
-
Amazon's push into telehealth knocks shares of Hims & Hers — Nov 14th, 2024
Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing for telehealth visits....
-
Telehealth firm Hims & Hers launches weight-loss drug shortage tracker — Nov 13th, 2024
Hims & Hers Health on Wednesday launched a tracker for popular weight-loss and diabetes drugs that allows patients to share details about their challenges finding treatments such as Novo Nordisk's Wegovy....
-
Guardant Health Stock Sees RS Rating Jump To 83 — Nov 20th, 2024
On Wednesday, Guardant Health stock got a positive adjustment to its Relative Strength (RS) Rating, from 75 to 83. This exclusive rating from Investor's Business Daily measures price action with a 1 (worst) to 99 (best) score. Continue reading View comments...
-
Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers — Oct 21st, 2024
Bringing expertise on women’s health at every age, Shepherd joins Hims & Hers to help more women access personalized care. (Photo: Business Wire) Bringing expertise on women’s health at every age, Shepherd joins Hims & Hers to help more women access personalized care SAN FRANCISCO, O...
Portfolio
Comprised of 1 portfolios